Reversal of refractory septic shock with drotrecogin alpha (activated)

Intensive Care Medicine

Volumn 35, Issue 7, 2009, Pages 1204-1209

  Vieillard Baron, A ^a   Caille, V ^a   Charron, C ^a   Belliard, G ^a   Aegerter, P ^a   Page, B ^a   Jardin, F ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Circulatory failure; Drotrecogin alpha; Hemodiafiltration; Lactic acidosis; Multiple organ failure; Sepsis; Septic shock

Indexed keywords

ADRENALIN; DOBUTAMINE; DROTRECOGIN; NORADRENALIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUID RESUSCITATION; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; LACTIC ACIDOSIS; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT OUTCOME;

ACIDOSIS, LACTIC; AGED; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; PROTEIN C; RECOMBINANT PROTEINS; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67649336390     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1538-9     Document Type: Article

References (31)

1. G Bernard JL Vincent PF Laterre SP LaRosa JF Dhainaut A Lopez-Rodriguez JS Steingrub GE Garber JD Helterbrand EW Ely CJ Fisher Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group 2001 Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699 709 (Pubitemid 32204987)
2. JL Vincent G Bernard R Beale C Doig C Putensen JF Dhainaut A Artigas R Fumagalli W Macias T Wright K Wong DP Sundin MA Turlo J Janes 2005 Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implication for early treatment Crit Care Med 33 2266 2277 (Pubitemid 41437481)
3. P Eichacker C Natanson 2006 Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly N Engl J Med 19 1640 1642 (Pubitemid 44583953)
4. E Abraham PF Laterre R Garg H Levy D Talwar BL Trzaskoma B François JS Guy M Brückmann A Rea-Neto R Rossaint D Perrotin A Sablotzki N Arkins BG Utterback WL Macias 2005 Drotrecogin alfa (activated) treatment for adults with severe sepsis and a low risk of death N Engl J Med 353 1332 1341 (Pubitemid 41362701)
5. P Dellinger 2006 Recombinant activated protein C: decisions for administration Crit Care Med 34 530 531
6. B Page A Vieillard-Baron A Beauchet P Aegerter S Prin F Jardin 2005 Early veno-venous hemodiafiltration for sepsis-related multiple organ failure Crit Care 9 R755 R763
7. J Carlet 2006 Prescribing indications based on successful clinical trials in sepsis: a difficult exercise Crit Care Med 34 525 531
8. RC Bone RA Balk FB Cerra RP Dellinger AM Fein WA Knaus RM Schein WJ Sibbald 1992 Definition for sepsis and organ failure and guideline for the use of innovative therapies in sepsis Chest 101 1644 1655
9. JR Le Gall S Lemeshow F Saulnier 1993 A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study JAMA 270 2957 2963 (Pubitemid 24000804)
10. JL Vincent R Moreno J Takala S Willatts A De Mendonça H Bruining C Reinhart P Suter L Thijs 1996 The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure Intensive Care Med 22 707 710 (Pubitemid 26254283)
11. R McCabe G Jackson 1962 Gram-negative bacteremia: I. Etiology and ecology Ann Intern Med 110 847 855
12. A Vieillard-Baron S Prin K Chergui O Dubourg F Jardin 2003 Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography Am J Respir Crit Care Med 168 1270 1276 (Pubitemid 37487319)
13. A Vieillard-Baron V Caille C Charron G Belliard B Page F Jardin 2008 Actual incidence of global left ventricular hypokinesia in adult septic shock Crit Care Med 36 1701 1706
14. D Annane V Sebille C Charpentier P Bollaert B François J Korach M Cappello Y Cohen E Azoulay G Troche P Chaumet-Riffaut E Bellissant 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 862 871 (Pubitemid 34898534)
15. R Dellinger MM Levy J Carlet International Surviving Sepsis Campaign guidelines committee 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock Crit Care Med 36 296 327
16. B Page A Vieillard-Baron A Beauchet Ph Aegeter S Prin F Jardin 2003 Low stretch ventilator strategy in acute respiratory distress syndrome: eight years of clinical experience in a single center Crit Care Med 31 765 769 (Pubitemid 36379580)
17. R Bellomo J Kellum C Ronco 2001 Acute renal failure: time for consensus Intensive Care Med 27 1685 1688 (Pubitemid 33139827)
18. W Ely PF Laterre D Angus J Helterbrand H Levy JF Dhainaut JL Vincent W Macias G Bernard for the PROWESS investigators 2003 Drotrecogin alfa (activated) administration across clinically important subgroups of patients with a severe sepsis Crit Care Med 31 12 19 (Pubitemid 36151143)
19. PM Honore J Jamez M Wauthier PA Lee T Dugernier B Pirenne G Hanique JR Matson 2000 Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock Crit Care Med 28 3581 3587 (Pubitemid 30948994)
20. P Piccinni M Dan S Barbacini R Carraro E Lieta S Marafon N Zamperetti A Brendolan V D'Intini C Tetta R Bellomo C Ronco 2006 Early isovolemic hemofiltration in oliguric patients with septic shock Intensive Care Med 32 80 86 (Pubitemid 43039380)
21. R Cornejo P Downey R Castro C Romero T Regueira J Vega L Castillo M Andresen A Dougnac G Bugedo G Hernandez 2006 High-volume haemofiltration as salvage therapy in severe hyperdynamic septic shock Intensive Care Med 32 713 722
22. JL Vincent J O'Brien Jr A Wheeler X Wittebole R Garg BL Trzaskoma DP Sundin 2006 Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis Crit Care 10 R74
23. X Monnet B Lamia N Anguel C Richard G Bonmarchand JL Teboul 2005 Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients Intensive Care Med 31 1573 1576 (Pubitemid 41598671)
24. JR Legall J Klar S Lemeshow F Saulnier C Alberti A Artigas D Teres 1996 The logistic organ dysfunction score JAMA 275 802 810
25. D Angus W Linde-Zwirble J Lidicker G Clermont J Carcillo M Pinsky 2001 Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 1303 1310 (Pubitemid 32641789)
26. A Padkin C Goldfrad A Brady D Young N Black K Rowan 2003 Epidemiology of severe sepsis occurring in the first 24 h in intensive-care units in England, Walles, and Northern Ireland Crit Care Med 31 2332 2338 (Pubitemid 37100836)
27. JL Vincent V Sakf C Sprung M Ranieri K Reinhart H Gerlach R Moreno J Carlet JR Le Gall D Payen 2006 Sepsis in European intensive-care units: results of the SOAP study Crit Care Med 34 344 353 (Pubitemid 43145611)
28. D Annane Ph Aegerter MC Jars-Guincestre B Guidet 2003 Current epidemiology of septic shock. The CUB-Rea network Am J Respir Crit Care Med 168 165 172 (Pubitemid 36920969)
29. The EPISEPSIS Study Group 2004 EPISEPSIS/a reappraisal of the epidemiology and outcome of severe sepsis in French intensive-care units Intensive Care Med 30 580 588
30. O Abid S Akça P Haji-Michael JL Vincent 2000 Strong vasopressor support may be futile in the intensive-care unit patient with multiple organ failure Crit Care Med 55 947 949 (Pubitemid 30262060)
31. C Martin X Viviand M Leone X Thirion 2000 Effect of norepinephrine on the outcome of septic shock Crit Care Med 28 2758 2765 (Pubitemid 30676520)